Related Experiment Video
Updated: Jul 31, 2025
A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Transcriptome Sequencing of CeRNA Network Constructing in Status Epilepticus Mice Treated by Low-Frequency Repetitive
Shaotian Zhang1, Huihui Zou2, Xiaopei Zou2
1Department of Neurology, Neuroscience Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, No.13 Shi Liu Gang Rd, Haizhu District, Guangzhou, Guangdong, 510315, China.
Low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) alleviates epilepsy by regulating gene expression networks. This treatment impacts immune function and GABA-A receptor activity, suggesting novel therapeutic mechanisms for neurological disorders.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Repetitive transcranial magnetic stimulation (rTMS) shows promise for neurological and psychiatric conditions.
- Understanding the molecular mechanisms of rTMS, particularly its effects on gene regulation, is crucial for optimizing treatments.
Purpose of the Study:
- To investigate how low-frequency rTMS (LF-rTMS) exerts therapeutic effects in status epilepticus (SE) mice by analyzing competitive endogenous RNA (ceRNA) networks.
- To identify differentially expressed long non-coding RNAs (lncRNAs), messenger RNAs (mRNAs), and microRNAs (miRNAs) regulated by LF-rTMS.
Main Methods:
- High-throughput sequencing to analyze lncRNA, miRNA, and mRNA expression in SE mice treated with LF-rTMS versus sham rTMS.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.
- Construction and analysis of a gene-gene cross-linkage network, with verification by qRT-PCR.
Main Results:
- Significant differential expression of 1615 lncRNAs, 510 mRNAs, and 17 miRNAs between LF-rTMS and sham groups.
- GO analysis indicated roles for immune-associated mechanisms, biological processes, and GABA-A receptor activity.
- KEGG analysis revealed associations with T cell receptor signaling, primary immune deficiency, and Th17 cell differentiation pathways.
Conclusions:
- LF-rTMS alleviates SE by modulating GABA-A receptor activity, enhancing immune functions, and influencing biological processes.
- The findings suggest that ceRNA regulatory networks are key molecular mechanisms underlying LF-rTMS efficacy in epilepsy treatment.
